Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMO1 in Retinal Vein Occlusive Macular Edema
NCT07708142Phase 3Recruiting
- Sponsor
- Sangmyung Innovation
- Start
- Jan 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in retinal vein occlusion (RVO), sponsored by Sangmyung Innovation. Started Jan 2026; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
retinal vein occlusion (RVO)
Beyond the preview
Go deeper on NCT07708142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07708142.